Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib.

Respir Med Case Rep

Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Published: June 2024

A 69-year-old woman was diagnosed with idiopathic interstitial pneumonia (IIP). The patient underwent a combination therapy of steroid therapy and intravenous cyclophosphamide, long-term oxygen therapy, and the initiation of Nintedanib. However, there was no improvement in IIP, and as a result, the activities of daily living also declined. As one of the various examinations conducted, the results of the right heart catheterization diagnosed the patient with mild pulmonary hypertension, and Macitentan therapy was initiated. The subsequent clinical course appeared to show an improvement in Idiopathic Interstitial Pneumonia (IIP) by adding Macitentan therapy to Nintedanib therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220517PMC
http://dx.doi.org/10.1016/j.rmcr.2024.102058DOI Listing

Publication Analysis

Top Keywords

idiopathic interstitial
12
interstitial pneumonia
12
improvement idiopathic
8
adding macitentan
8
pneumonia iip
8
macitentan therapy
8
therapy
6
pneumonia adding
4
macitentan patient
4
patient unresponsive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!